Picture of CME logo

CME CME News Story

0.000.00%
us flag iconLast trade - 00:00
FinancialsConservativeLarge CapNeutral

CME veteran chief Duffy steps down; Fitzpatrick named first woman CEO (updated)

UPDATE 5-CME veteran chief Duffy steps down; Fitzpatrick named first woman CEO

CME taps insider Fitzpatrick as next CEO

Duffy to become executive chairman on March 1

CME shares fall after leadership transition unveiled

Duffy credited with transforming CME into derivatives giant

Recasts, adds background on Duffy

By Manya Saini, Arasu Kannagi Basil, Anirban Sen and Ann Saphir

- Terry Duffy, the longtime leader of CME Group CME.O who reshaped the derivatives exchange through two big mergers, plans to step down from his role and make way for insider Lynne Fitzpatrick, who will take over as the company's first female CEO.

The leadership transition comes at a time when exchanges are attempting to diversify their businesses beyond trading floors and futures contracts. Operators are investing heavily in data, software and newer products such as prediction markets across the industry as part of the shift.

Duffy began his career in 1980 at CME — which at the time was known as the "Merc" and was the smaller and newer of the two big Chicago futures exchanges — as a trader in the hog pit, writing buy and sell orders on paper and using his hands to close deals.

Since those days, CME and its competitors have undergone a major transformation as floor-based trading has been largely replaced by electronic trading.

"Since first stepping onto the trading floor in the 1980s, I have been a believer that strong, transparent and regulated markets are a powerful force in driving progress for economies, businesses and individuals," Duffy said in a statement on Wednesday. Duffy will hand over the CEO title to Fitzpatrick on March 1 and transition to the role of executive chairman.

Known for his distinct gravelly voice and outspoken demeanor, Duffy steered CME through the global financial crisis and completed the industry's first major merger with crosstown rival the Chicago Board of Trade in 2007. A year later, CME orchestrated a takeover of the New York Mercantile Exchange.

Shares of CME, which currently has a market capitalization of about $90 billion, were trading down nearly 5% on Wednesday on news of Duffy stepping down.

DISRUPTIVE THREATS

The leadership transition comes as the traditional derivatives industry is grappling with the emergence of perpetual futures, or "perps" as they are popularly known, and the explosion of prediction markets.

"Shares (of CME) are under pressure this morning," said Piper Sandler analyst Patrick Moley in a note on Wednesday. "Stating the obvious — the timing of the leadership transition isn’t ideal with the current narrative around perpetual futures weighing on exchange stocks, but we do not at all believe the two are in any way connected." Moley said he does not believe that perps pose a threat to the CME’s almost entirely commercial / institutional business.

At an industry conference earlier in June, Duffy warned that U.S. regulators were creating systemic risk by green-lighting the trading of perps and criticized the ​Commodity Futures Trading Commission's (CFTC) process for approving the novel products.

"(Are perps) a healthy market structure for retail to participate in? I would say absolutely not. It's irresponsible, as far as I see," Duffy told Reuters in an interview on June 4.

However, CME has made strides to enter the predictions market, teaming up with sports betting firm FanDuel last year to launch a prediction markets platform across various states.

Fitzpatrick was named president and chief financial officer in 2024 after serving as CFO since 2023 and deputy CFO since 2022. A longtime insider, she joined CME in 2006 and has held a series of senior finance and leadership roles.

She will also join the company's board when she takes over as CEO, CME said, adding that it would kick off a search for potential candidates to succeed Fitzpatrick as CFO.

Fitzpatrick becomes one of the few women to lead a major Wall Street firm, alongside Citi's C.N Jane Fraser and Nasdaq's NDAQ.O Adena Friedman.

END OF AN ERA

Duffy's decision to hand over the reins marks the end of an era at the exchange he helped transform over the past three decades from a floor-trading exchange to an electronic markets powerhouse. He led its landmark public listing, making it the first U.S. exchange to go public in 2002. CME's shares have gained manifold since its listing, and the exchange traded an average daily volume of 28.1 million contracts last year.

Duffy, who was appointed chairman in 2002 and has led CME for more than a quarter century, is widely regarded as one of the exchange industry's most prominent figures.

Analysts at RBC Capital Markets also described the 2008 acquisition of the New York Mercantile Exchange, as well as more recent initiatives like the 2021 Google Cloud partnership and 2025 venture with FanDuel, as Duffy's leadership accomplishments.

Duffy became CME's executive chairman in 2006, added the title of president in 2012 and assumed his current role as chairman and CEO in 2016.

Under him, CME cemented its position as the world's leading derivatives marketplace, with its commodity exchanges serving as a hub for global price discovery.

Energy producers, farmers, manufacturers and investors rely on its markets to hedge risks and navigate volatility across some of the world's most important commodities.

Several analysts described Duffy as "legendary" but said the move was not a complete surprise.

"Duffy's CEO employment contract was scheduled to run through the rest of this year, and given the uncertainty regarding potential succession, it is not completely surprising to us that a succession plan has been announced," Barclays analysts said in a note.


(Reporting by Manya Saini and Arasu Kannagi Basil in Bengaluru and Anirban Sen in New York; Additional reporting by Ann Saphir; Editing by Megan Davies, Tasim Zahid, Pooja Desai and Daniel Wallis)

((Manya.Saini@thomsonreuters.com; X: manya__saini;))

Recent news on CME

See all news